ConductScience.org, home

Paper39257585

The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines.

McCann N and 3 others. Front Immunol, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines. Papers, record 39257585. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39257585

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.68, provisional
iCite
Revised in PubMed
2026-10-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McCann NNaina
2Paganotti Vicentine MMargarete
3Kim YCYoung Chan
4Pollard AJAndrew J

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Salmonella VaccinesMajor topic
Salmonella InfectionsMajor topic
Humans
Salmonella typhi
Vaccination
Vaccine Efficacy
Typhoid Fever
Salmonella

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132968012Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G.mSphere2020https://conductscience.org/library/papers/32968012PubMed
29607841Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.J Infect Dis1998https://conductscience.org/library/papers/9607841PubMed
323593253Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.PLoS One2013https://conductscience.org/library/papers/23593253PubMed
46028241Appraisal of typhoid vaccine in experimentally infected human subjects.Trans Am Clin Climatol Assoc1967https://conductscience.org/library/papers/6028241PubMed
54916913Typhoid fever: pathogenesis and immunologic control.N Engl J Med1970https://conductscience.org/library/papers/4916913PubMed
638199617Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK.BMJ Open2024https://conductscience.org/library/papers/38199617PubMed
728965718
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
Lancet2017https://conductscience.org/library/papers/28965718PubMed
81538539Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.JAMA1992https://conductscience.org/library/papers/1538539PubMed
912228290Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans.Infect Immun2002https://conductscience.org/library/papers/12228290PubMed
1034714686Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses.Sci Immunol2021https://conductscience.org/library/papers/34714686PubMed
1135921476Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses.Sci Transl Med2022https://conductscience.org/library/papers/35921476PubMed
122669099Progress in vaccines against typhoid fever.Rev Infect Dis1989https://conductscience.org/library/papers/2669099PubMed
136966763Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.N Engl J Med1980https://conductscience.org/library/papers/6966763PubMed
1430849494Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902.Clin Immunol2019https://conductscience.org/library/papers/30849494PubMed
154916916Typhoid fever: pathogenesis and immunologic control. 2.N Engl J Med1970https://conductscience.org/library/papers/4916916PubMed
1637225278
Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.
BMJ Open2023https://conductscience.org/library/papers/37225278PubMed
1737589596Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina Faso.J Pediatric Infect Dis Soc2023https://conductscience.org/library/papers/37589596PubMed
1829387052Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model.Front Immunol2017https://conductscience.org/library/papers/29387052PubMed
1937402153Molecular correlates of vaccine-induced protection against typhoid fever.J Clin Invest2023https://conductscience.org/library/papers/37402153PubMed
201498769Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.Clin Microbiol Rev1992https://conductscience.org/library/papers/1498769PubMed

See all 45 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41471961Characterization of a Luminescence-Based Serum Bactericidal Activity Assay for Human Sera Against a Panel of Salmonella Strains.Microorganisms2025https://conductscience.org/library/papers/41471961PubMed
40318346Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.Vaccine2025https://conductscience.org/library/papers/40318346PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39257585

GET https://conductscience.org/api/papers/v1/39257585/references?page=2